China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. The company is headquartered in Haikou, Hainan and currently employs 215 full-time employees. The company went IPO on 2000-02-15. The firm is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for high-incidence and high-mortality diseases and medical conditions prevalent in the PRC. The firm's products include dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The firm's products and solutions are mainly applied in the treatment of various diseases and medical conditions. The firm mainly operates in the domestic market.
CPHI stock price ended at $1 on 星期三, after rising 12.36%
On the latest trading day May 13, 2026, the stock price of CPHI rose by 12.36%, climbing from $0.90 to $1.00. Throughout the session, the stock experienced a volatility of 47.50%, with prices fluctuating between a daily low of $0.80 and a high of $1.18. Alongside this price increase, trading volume also rose by 12.0M shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 730.4K shares were traded, amounting to a market value of approximately $40.5M.
¿Cómo se aplican los indicadores de análisis técnico a CPHI?
Según el análisis técnico, China Pharma Holdings Inc tiene una señal agregada de Neutral. China Pharma Holdings Inc tiene 3 señales de compra, 1 señales neutrales y 3 señales de venta.
¿Cuáles son los niveles de retroceso de Fibonacci para CPHI?
El nivel de retroceso de Fibonacci de China Pharma Holdings Inc es 在 38.2% 和 50% 之间。
¿Cuál es el RSI de China Pharma Holdings Inc?
El RSI de China Pharma Holdings Inc es actualmente 90.00, lo que indica una condición 超买
¿Cuál es el precio de China Pharma Holdings Inc para los próximos 12 meses?
El precio de China Pharma Holdings Inc CPHI para los próximos 12 meses se estima en $0.
¿Hasta dónde se espera que suba China Pharma Holdings Inc?
Según los analistas de Wall Street, se espera que China Pharma Holdings Inc alcance una previsión alta de $0.